Abstract

Background: Hypertension is prevalent all over the world and represent a major health problem. Dyslipidemia is a major cause of cardiovascular morbidity and mortality. There is a correlation between hyperlipidemia and hypertension.Aim of study: to find out the prevalence of dyslipidemia in Iraqi hypertension patients, and to find out how many of them on statin therapy, and how many reach target according to the last guidelinesPatients and methods: a cross-sectional study conducted in outpatient clinic in Salahaddin General Hospital in Tikrit City. About 344 hypertensive patients were included in this study. A questionnaires including general information about patients were filled and venous blood was drawn from every patient and sent for hospital lab to measure necessary investigations. ASCVD risk score was calculated for every patient by ASCVD Risk Estimator Plus. Then data were analyzed by application of Microsoft excel program and Statistical Package for Social Sciences (SPSS) version 23.Results: (49%) of hypertension patients had total cholesterol of >200 mg/dl, (63.4%) had LDL of ?115 mg/dl, (57.6%) had HDL of <40 mg/dl, and (54.1%) had triglycerides of ?150mg/dl. Smoker patients in this study had highest ASCVD risk score (12.65±6.63%) followed by former smokers (7.36±3.56%) and non-smokers (6.02±4.16%).Only 76 (22.1%) of hypertension patients were on statin therapy for hyperlipidemia and only 18 (23.7%) of them reaching target LDL level according to 2016 ESC/EAS guidelines. While 268 (77.9%) of hypertension patients had no statin therapy and only 65 (24.3%) of them had LDL level within target.Conclusion: Hyperlipidemia is very prevalent in hypertension patients in Tikrit City, despite that only one of five receiving treatment and only one of four from those who received treatment reaching the target of LDL level according to 2016 ESC/EAS guidelines, and three of four of those who are on no treatment are out of the target. This is a major health problem need attention.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call